Increasing Contraception Utilization Among Women Prescribed Teratogenic Medications (TLC)
|ClinicalTrials.gov Identifier: NCT01624155|
Recruitment Status : Unknown
Verified February 2013 by Christina Chambers, University of California, San Diego.
Recruitment status was: Recruiting
First Posted : June 20, 2012
Last Update Posted : February 22, 2013
University of California, San Diego
Information provided by (Responsible Party):
Christina Chambers, University of California, San Diego
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||April 2013|
|Estimated Study Completion Date :||April 2013|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Mody SK, Wu J, Ornelas M, Kernahan C, Salas E, Kao K, Felix R, Chambers C. Using the electronic medical record to refer women taking category D or X medications for teratogen and contraceptive counseling. Birth Defects Res A Clin Mol Teratol. 2015 Jul;103(7):644-7. doi: 10.1002/bdra.23396. Epub 2015 Jun 23.